Fractyl Health Inc. Commo... (GUTS)
NASDAQ: GUTS
· Real-Time Price · USD
1.03
0.05 (5.38%)
At close: Aug 15, 2025, 3:59 PM
1.03
-0.48%
After-hours: Aug 15, 2025, 07:52 PM EDT
Fractyl Health Common Stock Income Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q4 2021 | Q3 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Revenue | 17K | 60K | 93K | 97K | 119K | 148K | 120K | 113K | 77K | 5K | n/a | n/a | n/a | n/a |
Cost of Revenue | 244K | 268K | -3K | 52K | 154K | 177K | 241K | 320K | 211K | 312K | 389K | 308K | 683K | 535K |
Gross Profit | -280K | -261K | 43K | 45K | -35K | -29K | -121K | -207K | -134K | -307K | -389K | -308K | -683K | -535K |
Operating Income | -99.84M | -96.75M | -93.53M | -81.3M | -71.38M | -60.27M | -50.84M | -49.27M | -46.95M | -47.05M | -43.72M | -32.31M | -35.47M | -23.5M |
Interest Income | 2.18M | 3.55M | 4.15M | 3.88M | 3.16M | 1.94M | 1.26M | 1.21M | 1.27M | 1.11M | 695K | 284K | n/a | n/a |
Pretax Income | -99.77M | -89.11M | -68.69M | -62.9M | -55.48M | -68.48M | -77.09M | -68.77M | -64.09M | -46.38M | -43.58M | -32.72M | -37.18M | -24.65M |
Net Income | -99.77M | -89.11M | -68.69M | -62.9M | -55.48M | -68.48M | -77.09M | -68.77M | -64.09M | -46.38M | -43.58M | -32.72M | -37.18M | -24.65M |
Selling & General & Admin | 19.98M | 21.3M | 23.05M | 20.9M | 20.52M | 17.04M | 12.64M | 12.57M | 11.17M | 12.42M | 11.99M | 9.27M | 8.8M | 4.8M |
Research & Development | 79.87M | 75.48M | 70.47M | 60.36M | 50.73M | 43.11M | 38.04M | 36.49M | 35.64M | 34.32M | 31.34M | 22.73M | 25.99M | 18.17M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 99.85M | 96.78M | 93.52M | 81.26M | 71.25M | 60.15M | 50.68M | 49.06M | 46.61M | 46.54M | 43.13M | 31.79M | 34.79M | 22.96M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 349K | 697K | 697K | 1.49M | 1.14M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -1.1M | -1.1M | -1.1M | -1.1M | -6.2M | -6.2M | -6.2M | -6.2M | n/a | n/a |
Cost & Expenses | 73.78M | 96.81M | 93.62M | 81.4M | 71.5M | 60.42M | 50.96M | 49.38M | 46.82M | 46.85M | 43.51M | 32.1M | 35.47M | 23.5M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 49.04M | 48.87M | 48.76M | 47.97M | 47.9M | 47.9M | 47.61M | 47.61M | 47.75M | 47.9M | 47.61M | 47.61M | 47.61M | 47.61M |
Shares Outstanding (Diluted) | 49.04M | 48.87M | 48.76M | 47.97M | 47.9M | 47.9M | 47.61M | 47.61M | 47.75M | 47.9M | 47.61M | 47.61M | 47.61M | 47.61M |
EPS (Basic) | -2.05 | -1.84 | -1.46 | -1.35 | -1.29 | -1.56 | -1.7 | -1.53 | -1.34 | -0.97 | -0.91 | -0.68 | -0.78 | -0.52 |
EPS (Diluted) | -2.05 | -1.84 | -1.46 | -1.35 | -1.29 | -1.56 | -1.7 | -1.53 | -1.34 | -0.97 | -0.91 | -0.68 | -0.78 | -0.52 |
EBITDA | -99.12M | -95.83M | -92.85M | -80.81M | -71.01M | -60.01M | -50.52M | -48.91M | -46.59M | -46.83M | -43.46M | -32.13M | -35.01M | -22.98M |
EBIT | -73.76M | -96.75M | -93.53M | -81.3M | -71.38M | -60.27M | -50.84M | -49.27M | -46.95M | -47.25M | -43.93M | -32.52M | -35.69M | -23.51M |
Depreciation & Amortization | 722K | 914K | 677K | 492K | 367K | 259K | 286K | 329K | 326K | 390K | 470K | 389K | 683K | 535K |